help button home button Am J Pathol ASIP WHAT IS IT?
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Originally published online as doi:10.2353/ajpath.2008.080414 on October 30, 2008

Published online before print October 30, 2008
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Material
Right arrow All Versions of this Article:
ajpath.2008.080414v1
173/6/1595    most recent
Right arrow Purchase Article
Right arrow View Shopping Cart
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Orozco, A. F.
Right arrow Articles by Lewis, D. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Orozco, A. F.
Right arrow Articles by Lewis, D. E.
(American Journal of Pathology. 2008;173:1595-1608.)
© 2008 American Society for Investigative Pathology
DOI: 10.2353/ajpath.2008.080414

Membrane Protected Apoptotic Trophoblast Microparticles Contain Nucleic Acids

Relevance to Preeclampsia

Aaron F. Orozco*, Carolina J. Jorgez{dagger}, Cassandra Horne*, Deborah A. Marquez-Do{dagger}, Matthew R. Chapman{dagger}, John R. Rodgers*, Farideh Z. Bischoff{ddagger} and Dorothy E. Lewis*§

From the Department of Immunology,* and the Department of Obstetrics and Gynecology,{dagger} Baylor College of Medicine, Houston, Texas; Biocept, Inc.,{ddagger} San Diego, California; and the Departments of Internal Medicine, Microbiology and Immunology, and Pathology,§ University of Texas Medical Branch, Galveston, Texas

Microparticles (MPs) that circulate in blood may be a source of DNA for molecular analyses, including prenatal genetic diagnoses. Because MPs are heterogeneous in nature, however, further characterization is important before use in clinical settings. One key question is whether DNA is either bound to aggregates of blood proteins and lipid micelles or intrinsically associated with MPs from dying cells. To test the latter hypothesis, we asked whether MPs derived in vitro from dying cells were similar to those in maternal plasma. JEG-3 cells model extravillous trophoblasts, which predominate during the first trimester of pregnancy when prenatal diagnosis is most relevant. MPs were derived from apoptosis and increased over 48 hours. Compared with necrotic MPs, DNA in apoptotic MPs was more fragmented and resistant to plasma DNases. Membrane-specific dyes indicated that apoptotic MPs had more membranous material, which protects nucleic acids, including RNA. Flow cytometry showed that MPs derived from dying cells displayed light scatter and DNA staining similar to MPs found in maternal plasma. Quantification of maternal MPs using characteristics defined by MPs generated in vitro revealed a significant increase of DNA+ MPs in the plasma of women with preeclampsia compared with plasma from women with normal pregnancies. Apoptotic MPs are therefore a likely source of stable DNA that could be enriched for both early genetic diagnosis and monitoring of pathological pregnancies.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2008 by the American Society for Investigative Pathology.